{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:25:14Z","timestamp":1787034314434,"version":"build-2736575974"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Research in the area of hallmarks of cancer has opened the possibility of designing novel therapeutic interventions based on modulating cancer properties. Interestingly, the epithelial-mesenchymal transition (EMT), important in both tumour growth and metastasis, has not been targeted in prostate cancer (PCa). Previously, in a repositioning screen, three new chemicals that modulate EMT in PCa (LLSO1 - NNC-55-0396 dihydrochloride; LLSO2 - Nemadipine A; LLSO3 - Naltrexone hydrochloride) have been found. This study aims to investigate how they work mechanistically as well as the effect of these LLSOs on the properties of PCa cells both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Although these LLSOs exhibited varying effects on different cancer cell lines, all of them modulated EMT by inhibiting the migration of PCa cells. LLSO3 also exhibited a significant inhibitory effect on tumour growth\n                    <jats:italic>in vivo<\/jats:italic>\n                    , concomitant with an increase in the expression levels of E-cadherin. Further investigation was conducted to obtain mechanistic insights into the LLSO compounds mode of action. In conclusion, our work strongly supports that LLSO compounds may become important candidates for targeted therapeutics in prostate cancer.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1808307","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:36:38Z","timestamp":1787031398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulators of epithelial-mesenchymal transitions in prostate cancer: potential for novel therapeutics development"],"prefix":"10.3389","volume":"17","author":[{"given":"Jinxia","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Clinical and Biomedical Sciences, University of Exeter Medical School","place":["Exeter, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biomedical Sciences, University of Exeter Medical School","place":["Exeter, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biomedical Sciences, University of Exeter Medical School","place":["Exeter, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Duzgun","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biomedical Sciences, University of Exeter Medical School","place":["Exeter, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Oltean","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biomedical Sciences, University of Exeter Medical School","place":["Exeter, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000512277","article-title":"The role of calcium signaling in regulation of epithelial-mesenchymal transition","volume":"211","author":"Adiga","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.4049\/jimmunol.181.4.2831","article-title":"Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506","volume":"181","author":"Akool el","year":"2008","journal-title":"J. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biology9070142","article-title":"Inhibition on JNK mimics silencing of Wnt-11 mediated cellular response in androgen-independent prostate cancer cells","volume":"9","author":"Arisan","year":"2020","journal-title":"Biol. (Basel)."},{"key":"B4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S497","DOI":"10.21037\/tcr.2016.09.30","article-title":"Activation of calcineurin in cancer: many paths, one hub","volume":"5","author":"Brun","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer - from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B51","unstructured":"Prostate cancer incidence statistics: prostate cancer incidence by age\n          \n          \n          2024"},{"key":"B7","doi-asserted-by":"publisher","first-page":"104938","DOI":"10.1016\/j.phrs.2020.104938","article-title":"Opioid receptors beyond pain control: the role in cancer pathology and the debated importance of their pharmacological modulation","volume":"159","author":"Carli","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2005.05.010","article-title":"T-type calcium channel trigger p21ras signaling pathway to ERK in Cav3.1-expressed HEK293 cells","volume":"1054","author":"Choi","year":"2005","journal-title":"Brain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12779","DOI":"10.1038\/s41598-019-48976-7","article-title":"Calcineurin regulates cyclin D1 stability through dephosphorylation at T286","volume":"9","author":"Goshima","year":"2019","journal-title":"Sci. Rep-Uk"},{"key":"B11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.bcp.2013.09.001","article-title":"Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness","volume":"86","author":"Hirano","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-015-0171-4","article-title":"T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines","volume":"34","author":"Huang","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B14","unstructured":"Prostate cancer incidence in Western Europe, 2022\n          \n          \n          2024"},{"key":"B15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000512218","article-title":"Epithelial-mesenchymal transition (EMT) as a therapeutic target","volume":"211","author":"Jonckheere","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/Jci39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1073\/pnas.0603221103","article-title":"Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway (vol 102, pg 13909, 2005)","volume":"103","author":"Kang","year":"2006","journal-title":"P Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00109-014-1235-1","article-title":"NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1alpha signal transduction","volume":"93","author":"Kim","year":"2015","journal-title":"J. Mol. Med. Berl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.bi.49.070180.002421","article-title":"Calmodulin","volume":"49","author":"Klee","year":"1980","journal-title":"Annu. Rev. Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature04657","article-title":"A small-molecule screen in C. elegans yields a new calcium channel antagonist","volume":"441","author":"Kwok","year":"2006","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/molecules23061479","article-title":"Targeting transcription factors for cancer treatment","volume":"23","author":"Lambert","year":"2018","journal-title":"Molecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ceb.2013.01.008","article-title":"Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs","volume":"25","author":"Lamouille","year":"2013","journal-title":"Curr. Opin. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"ARTN e91577","DOI":"10.1371\/journal.pone.0091577","article-title":"The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial mesenchymal transition (EMT) in human lung cancer","volume":"9","author":"Lennon","year":"2014","journal-title":"Plos One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.omtm.2022.03.005","article-title":"A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts","volume":"25","author":"Li","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/14737140.2022.2037426","article-title":"Naltrexone at low doses (LDN) and its relevance to cancer therapy","volume":"22","author":"Liu","year":"2022","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"101028","DOI":"10.1016\/j.tranon.2021.101028","article-title":"Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K\/AKT\/mTOR pathway","volume":"14","author":"Liu","year":"2021","journal-title":"Transl. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12916-015-0405-5","article-title":"Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010","volume":"13","author":"Lloyd","year":"2015","journal-title":"Bmc Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells81011184","article-title":"The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-beta signaling in health and disease","volume":"186","author":"Massague","year":"2023","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","article-title":"E-cadherin in contact inhibition and cancer","volume":"37","author":"Mendonsa","year":"2018","journal-title":"Oncogene"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.3892\/ol.2019.10756","article-title":"NEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK\/EMT","volume":"18","author":"Meng","year":"2019","journal-title":"Oncol. Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","article-title":"The calcium-cancer signalling nexus","volume":"17","author":"Monteith","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10585-008-9186-y","article-title":"Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo","volume":"25","author":"Oltean","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1210\/en.2007-0145","article-title":"The immunophilin Ligands cyclosporin a and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms","volume":"148","author":"Periyasamy","year":"2007","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/febs.14383","article-title":"The retinamide VNLG-152 inhibits f-AR\/AR-V7 and MNK-eIF4E signaling pathways to suppress EMT and castration-resistant prostate cancer xenograft growth","volume":"285","author":"Ramamurthy","year":"2018","journal-title":"Febs J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1152\/physrev.2000.80.4.1483","article-title":"Calcineurin: form and function","volume":"80","author":"Rusnak","year":"2000","journal-title":"Physiol. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1158\/0008-5472.Can-17-3061","article-title":"T-type Ca2+ channels: t for targetable","volume":"78","author":"Sall\u00e1n","year":"2018","journal-title":"Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"792290","DOI":"10.3389\/fonc.2021.792290","article-title":"Opioid receptor-mediated and non-opioid receptor-mediated roles of opioids in tumour growth and metastasis","volume":"11","author":"Scroope","year":"2021","journal-title":"Front. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jdsr.2020.07.002","article-title":"Signaling pathways promoting epithelial mesenchymal transition in oral submucous fibrosis and oral squamous cell carcinoma","volume":"56","author":"Shetty","year":"2020","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"35454","DOI":"10.18632\/oncotarget.7721","article-title":"Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target","volume":"7","author":"Steven","year":"2016","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nm.2236","article-title":"Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance","volume":"16","author":"Tanaka","year":"2010","journal-title":"Nat. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","article-title":"Overcoming TGFbeta-mediated immune evasion in cancer","volume":"22","author":"Tauriello","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/medicines6030082","article-title":"Cellular and molecular mechanisms underlying prostate cancer development: therapeutic implications","volume":"6","author":"Testa","year":"2019","journal-title":"Medicines"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1002\/ijc.25938","article-title":"Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation","volume":"129","author":"Thaiparambil","year":"2011","journal-title":"Int. J. Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neo.2020.12.011","article-title":"Opioids drive breast cancer metastasis through the \u03b4-opioid receptor and oncogenic STAT3","volume":"23","author":"Tripolt","year":"2021","journal-title":"Neoplasia"},{"key":"B52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.Asn.0000043180.18456.47","article-title":"Ca\/calmodulin-dependent protein kinase II stimulates c-fos transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells","volume":"14","author":"Wang","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/1541-7786.Mcr-09-0221","article-title":"Sustained c-Jun-NH-Kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation","volume":"8","author":"Wang","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"ARTN 24606","DOI":"10.1038\/srep24606","article-title":"Twist-mediated epithelial-mesenchymal transition promotes breast tumor cell invasion via inhibition of Hippo Pathway","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep-Uk"},{"key":"B55","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/abbs\/gmaa169","article-title":"Successive treatment with naltrexone induces epithelial-mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells","volume":"53","author":"Wang","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"10116","DOI":"10.1523\/jneurosci.23-31-10116.2003","article-title":"A mechanism for the direct regulation of T-type calcium channels by Ca\/calmodulin-dependent kinase II","volume":"23","author":"Welsby","year":"2003","journal-title":"J. Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e28975","DOI":"10.4161\/jkst.28975","article-title":"STAT3 and epithelial-mesenchymal transitions in carcinomas","volume":"3","author":"Wendt","year":"2014","journal-title":"JAKSTAT"},{"key":"B58","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","article-title":"A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition","volume":"9","author":"Xu","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"B59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1023\/a:1011320027914","article-title":"Calmodulin target database","volume":"1","author":"Yap","year":"2000","journal-title":"J. Struct. Funct. Genomics."},{"key":"B60","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12967-017-1151-6","article-title":"Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway","volume":"15","author":"Zang","year":"2017","journal-title":"J. Transl. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"865816","DOI":"10.1155\/2015\/865816","article-title":"The regulatory role of MicroRNAs in EMT and cancer","volume":"2015","author":"Zaravinos","year":"2015","journal-title":"J. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tips.2011.11.002","article-title":"Targeting Src family kinases in anti-cancer therapies: turning promise into triumph","volume":"33","author":"Zhang","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.Can-16-2347","article-title":"Targetable T-type calcium channels drive glioblastoma","volume":"77","author":"Zhang","year":"2017","journal-title":"Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1808307\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:36:40Z","timestamp":1787031400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1808307\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":63,"alternative-id":["10.3389\/fphar.2026.1808307"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1808307","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1808307"}}